Alphatec Holdings Operating Income Over Time
| ATEC Stock | USD 13.93 0.77 5.85% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Alphatec Holdings Performance and Alphatec Holdings Correlation. Will Health Care Equipment & Supplies sector continue expanding? Could Alphatec diversify its offerings? Factors like these will boost the valuation of Alphatec Holdings. If investors know Alphatec will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alphatec Holdings data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.04) | Revenue Per Share | Quarterly Revenue Growth 0.304 | Return On Assets | Return On Equity |
Investors evaluate Alphatec Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Alphatec Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Alphatec Holdings' market price to deviate significantly from intrinsic value.
Understanding that Alphatec Holdings' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alphatec Holdings represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Alphatec Holdings' market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Alphatec Holdings and related stocks such as LivaNova PLC, Surgery Partners, and Legend Biotech Corp Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LIVN | (5.5 M) | 60.9 M | 78.3 M | 80 M | 80 M | 88.7 M | (27.6 M) | 95.7 M | (248.1 M) | (171.6 M) | (273.9 M) | (784 K) | (76.8 M) | (68.5 M) | 129.1 M | 116.1 M | 122 M |
| SGRY | 60.5 M | 60.5 M | 60.5 M | 58.2 M | 50.8 M | 144.8 M | 196.5 M | 158.2 M | 77.8 M | 235.9 M | 183 M | 302.2 M | 345.2 M | 328 M | 348.8 M | 401.1 M | 210.7 M |
| LEGN | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | 13.8 M | (1.5 M) | (132.5 M) | (313.3 M) | (392.3 M) | (455.6 M) | (439.5 M) | (303.2 M) | (272.9 M) | (286.6 M) |
| SRRK | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (16.2 M) | (25 M) | (50.7 M) | (54.5 M) | (86.9 M) | (129.9 M) | (134.4 M) | (171.3 M) | (252.1 M) | (226.8 M) | (215.5 M) |
| IRON | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (34 M) | (30.9 M) | (47.5 M) | (91.1 M) | (129.7 M) | (116.7 M) | (110.9 M) |
| HTFL | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (72.9 M) | (61.2 M) | (70.4 M) | (73.9 M) |
| IDYA | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (36.4 M) | (44.3 M) | (35.3 M) | (50.3 M) | (62.5 M) | (134.4 M) | (327 M) | (159.3 M) | (151.3 M) |
| ADPT | (44.5 M) | (44.5 M) | (44.5 M) | (44.5 M) | (44.5 M) | (44.5 M) | (44.5 M) | (44.5 M) | (49.8 M) | (78.4 M) | (152.8 M) | (209 M) | (200.2 M) | (227 M) | (162.5 M) | (57.1 M) | (60 M) |
| ZLAB | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (16.3 M) | (38.5 M) | (51.4 M) | (141.8 M) | (203.2 M) | (301.8 M) | (700.1 M) | (404.4 M) | (366.6 M) | (282.1 M) | (253.9 M) | (266.6 M) |
| CDTX | (792 K) | (792 K) | (792 K) | (1.1 M) | (11.6 M) | (32.3 M) | (48.4 M) | (55.7 M) | (63.3 M) | (41.7 M) | (71.8 M) | (42.3 M) | (29.7 M) | (27.1 M) | (176.1 M) | (158.5 M) | (150.6 M) |
Alphatec Holdings and related stocks such as LivaNova PLC, Surgery Partners, and Legend Biotech Corp Operating Income description
Operating Income is the amount of profit realized from Alphatec Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Alphatec Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Alphatec Holdings | ATEC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1950 Camino Vida |
| Exchange | NASDAQ Exchange |
USD 13.93
Check out Alphatec Holdings Performance and Alphatec Holdings Correlation. For information on how to trade Alphatec Stock refer to our How to Trade Alphatec Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Alphatec Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.